Immune activation and nutritional status in adult Crohn's disease patients

Digestive and Liver Disease

Volumn 37, Issue 6, 2005, Pages 424-431

  Reimund, J M ^a   Arondel, Y ^a   Escalin, G ^a   Finck, G ^a   Baumann, R ^a   Duclos, B ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

Crohn's disease; Insulin like growth factor I; Interleukin 1 ; Transthyretin; Tumour necrosis factor alpha; Vitamin A

Indexed keywords

ACUTE PHASE PROTEIN; ALBUMIN; AZATHIOPRINE; C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; MESALAZINE; NEOPTERIN; OROSOMUCOID; PREALBUMIN; RETINOL; RETINOL BINDING PROTEIN; SOMATOMEDIN C; STEROID; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; INTERLEUKIN 1; PLASMA PROTEIN; SOMATOMEDIN BINDING PROTEIN 1;

ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; COLON RESECTION; CONTROLLED STUDY; CORRELATION FUNCTION; CROHN DISEASE; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MALE; NUTRITIONAL STATUS; PROTEIN DEPLETION; PROTEIN SYNTHESIS; SKINFOLD THICKNESS; BLOOD; CASE CONTROL STUDY; IMMUNOLOGY; MULTIVARIATE ANALYSIS; PHYSIOLOGY; SOLUBILITY;

ADULT; BIOLOGICAL MARKERS; BLOOD PROTEINS; BLOOD SEDIMENTATION; BODY MASS INDEX; BODY WEIGHT; CASE-CONTROL STUDIES; CROHN DISEASE; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INTERLEUKIN-1; MALE; MULTIVARIATE ANALYSIS; NEOPTERIN; NUTRITIONAL STATUS; RECEPTORS, INTERLEUKIN-2; SOLUBILITY; VITAMIN A;

EID: 26944485212     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2005.01.010     Document Type: Article

References (40)

1. Ingenbleek Y., and Bernstein L. The stressful condition as a nutritionally dependent adoptive dichotomy. Nutrition 15 (1999) 305-320
2. Shanahan F. Crohn's disease. Lancet 359 (2002) 62-69
3. Han P.D., Burke A., Baldassano R.N., Rombeau J.L., and Lichtenstein G.R. Nutrition and inflammatory bowel disease. Gastroenterol Clin North Am 28 (1999) 423-443
4. Reimund J.M., Duclos B., Sapin R., Derlon A., Chamouard P., and Baumann R. Systemic tumor necrosis factor in Crohn's disease: relationship to disease activity and circulating acute phase reactants. Eur J Gastroenterol Hepatol 4 (1992) 919-923
5. Mahida Y.R., Kurlac L., and Hawkey C.J. High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis. Gut 32 (1991) 1531-1534
6. Reimund J.M., Wittersheim C., Dumont S., Muller C., Baumann R., Poindron P., et al. Mucosal inflammatory cytokine production by intestinal biopsies. J Clin Immunol 16 (1996) 144-150
7. Schreiber S., Nikolaus S., Hampe J., Hamling J., Koop I., Groessner B., et al. Tumour necrosis factor α and interleukin 1β in relapse of Crohn's disease. Lancet 353 (1999) 459-461
8. van Hees P.A.M., van Elteren P.H., van Lier H.J.J., and van Tongeren J.H. An index of inflammatory activity in patients with Crohn's disease. Gut 21 (1980) 279-286
9. Ingenbleek Y., and Carpentier Y.A. A prognostic inflammatory and nutritional index scoring critically ill patients. Int J Vit Nutr Res 55 (1985) 91-101
10. Jeejeebhoy K.N., and Ostro M.J. Nutritional consequences and therapy in inflammatory bowel disease. In: Kirsner J.B., and Shorter RG. (Eds). Inflammatory bowel disease (1988), Lea and Febinger, Philadelphia 513-528
11. Olson J.A. Vitamin A. In: Ziegler E.E., and Filer Jr. L.J. (Eds). Present knowledge in nutrition (1996), ILSI Press, Washington, DC 109-119
12. Le Roith D. Insulin-like growth factors. N Engl J Med 336 (1997) 633-640
13. Powell-Tuck J., Garlick P.J., Lennard-Jones J.E., and Waterlow J.C. Rates of whole body protein synthesis and breakdown increase with the severity of inflammatory bowel disease. Gut 25 (1984) 460-464
14. Thomas A.G., Miller V., Taylor F., Maycock P., Scrimgeour C.M., and Rennie M.J. Whole body protein turnover in childhood Crohn's disease. Gut 33 (1992) 675-677
15. Rigaud D., Cerf M., Angel A.L., Sobahni I., Carduner M.J., and Mignon M. Augmentation de la dépense énergétique de repos lors des poussées de la maladie de Crohn. Gastroenterol Clin Biol 17 (1993) 932-937
16. Schneeweiss B., Lochs H., Zauner C., Fischer M., Wyatt J., Maier-Dobersberger T., et al. Energy and substrate metabolism in patients with active Crohn's disease. J Nutr 129 (1999) 844-848
17. Al-Jaouni R., Hébuterne X., Pouget I., and Rampal P. Energy metabolism and substrate oxidation in patients with Crohn's disease. Nutrition 16 (2000) 173-178
18. Capristo E., Mingrone G., Addolorato G., Greco A.V., and Gasbarrini G. Metabolic features of inflammatory bowel disease in a remission phase of the disease activity. J Intern Med 243 (1998) 339-347
19. Perlmutter D.H., Dinarello C.A., Punsal P.I., and Colten H.R. Cachectin/tumor necrosis factor regulates hepatic acute phase gene expression. J Clin Invest 78 (1986) 1349-1354
20. Warren R.S., Donner D.B., Starnes Jr. H.F., and Brennan M.F. Modulation of endogenous hormone action by recombinant human tumor necrosis factor. Proc Natl Acad Sci USA 84 (1987) 8619-8622
21. Jones T.H., and Kennedy R.L. Cytokines and hypothalamic-pituitary function. Cytokine 37 (1993) 867-871
22. Kirschner B.S., and Sutton M.M. Somatomedin-C levels in growth-impaired children and adolescents with chronic inflammatory bowel disease. Gastroenterology 91 (1986) 830-836
23. Thomas A.G., Holly J.M., Taylor F., and Miller V. Insulin like growth factor-I, insulin like growth factor binding protein-1 and insulin in childhood Crohn's disease. Gut 34 (1993) 944-947
24. Griffiths A.M., Nguyen P., Smith C., MacMillan J.H., and Sherman P.M. Growth and clinical course of children with Crohn's disease. Gut 34 (1993) 939-943
25. Katsanos K.H., Tsatsoulis A., Christodoulou D., Challa A., Katsaraki A., and Tsianos E.V. Reduced serum insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 levels in adults with inflammatory bowel disease. Growth Horm IGF Res 11 (2001) 364-367
26. Gronbaek H., Thogersen T., Frystyk J., Vogel I., Rasch R., and Flyvbjerg A. Low free and total insulin-like growth factor I (IGF-I) and IGF binding protein-3 levels in chronic inflammatory bowel disease: partial normalization during predinisone treatment. Am J Gastroenterol 97 (2002) 673-678
27. Street M.E., de'Angelis G.L., Camacho-Hübner C., Giovannelli G., Ziveri M.A., Bacchini P.L., et al. Relationships between serum IGF-1, IGFBP-2, interleukin-1beta and interleukin-6 in inflammatory bowel disease. Horm Res 61 (2004) 159-164
28. Isley W.L., Underwood L.E., and Clemmons D.R. Dietary components that regulate serum somatomedin C concentrations in humans. J Clin Invest 71 (1983) 175-182
29. Underwood L.E. Nutritional regulation of IGF-I and IGFBPs. J Pediatr Endocrinol Metab 9 (1996) 303-312
30. Ketelslegers J.M., Maiter D., Maes M., Underwood L.E., and Thissen J.P. Nutritional regulation of the growth hormone and insulin-like growth factor-binding proteins. Horm Res 45 (1996) 252-257
31. Thissen J.P., and Verniers J. Inhibition by interleukin-1 beta and tumor necrosis factor-alpha of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture. Endocrinology 138 (1997) 1078-1084
32. Lang C.H., Nystrom G.J., and Frost R.A. Tissue-specific regulation of IGF-I and IGF-binding proteins in response to TNFalpha. Growth Horm IGF Res 11 (2001) 250-260
33. Beattie R.M., Camacho-Hübner C., Wacharasindhu S., Cotterill A.M., Walker-Smith J.A., and Savage M.O. Responsiveness of IGF-I and IGFBP-3 to therapeutic intervention in children and adolescents with Crohn's disease. Clin Endocrinol 49 (1998) 483-489
34. Akobeng A.I., Clayton P.E., Miller V., Hall C.M., and Thomas A.G. Low serum concentration of insulin-like growth factor-I in children with active Crohn's disease: effect of enteral nutritional support and glutamine supplementation. Scand J Gastroenterol 37 (2002) 1422-1427
35. Corkins M.R., Gohil A.D., and Fitzgerald J.F. The insulin-like growth factor axis in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 36 (2003) 228-234
36. Geerling B.J., Badart-Smooke A., Stockbrügger R.W., and Brummer R.J. Comprehensive nutritional status in patients with long-standing Crohn's disease currently in remission. Am J Clin Nutr 67 (1998) 919-926
37. Reimund J.M., Hirth C., Koehl C., Baumann R., and Duclos B. Antioxidant and immune status in active Crohn's disease: evidence for a possible relationship. Clin Nutr 19 (2000) 43-48
38. Bousvaros A., Zurakowski D., Duggan C., Law T., Rifai N., Goldberg N.E., et al. Vitamins A and E serum levels in children and young adults with inflammatory bowel disease: effect of disease activity. J Pediatr Gastroenterol Nutr 26 (1998) 129-134
39. Van Deventer S.J. Taming the mucosal immune response in Crohn's disease. Best Pract Res Clin Gastroenterol 16 (2002) 1035-1043
40. Bannerjee K., Camacho-Hubner C., Babinska K., Dryhust K.M., Edwards R., Savage M.O., et al. Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn's disease. J Pediatr Gastroenterol Nutr 38 (2004) 270-275